Immunova
Phase 1Our proprietary Nanolipogel™ platform delivers desired combinations of drugs in nanoparticle formulations to the disease microenvironment.
Founded
2018
Focus
Drug Delivery
About
Our proprietary Nanolipogel™ platform delivers desired combinations of drugs in nanoparticle formulations to the disease microenvironment.
Company Info
TypePrivate
Founded2018
LocationBoston, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile